Drug intelligence / Profile preview

[11C]DASB

Development stage
Phase 1
Lead developer
University of Toronto
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[11C]DASB is a highly selective radioligand developed for in vivo imaging of the serotonin transporter (SERT) using positron emission tomography (PET). It binds specifically to SERT sites in the brain, with high uptake in the midbrain and thalamus, intermediate levels in striatum, and modest to low levels in the neocortex and cerebellum. [11C]DASB has been successfully used to measure drug occupancy of SERT in vivo and has potential for monitoring changes in serotonin levels. It has suitable characteristics for evaluating the status of SERT in clinical settings and can detect SERT occupancy by selective serotonin reuptake inhibitors (SSRIs) such as paroxetine and citalopram.

Other names
11C-labeled 3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile11C-labeled 3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)benzonitrile
02

Targets

SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on [11C]DASB.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [11C]DASB.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call